Skip to main content
Log in

Acetaldehyde sequestration by d-penicillamine prevents ethanol relapse-like drinking in rats: evidence from an operant self-administration paradigm

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Previous experiments in our laboratory have shown that d-penicillamine (DP) (acetaldehyde sequestering agent) is able to block the increase in ethanol consumption observed after a period of imposed deprivation (the so-called alcohol deprivation effect (ADE)), using a non-operant paradigm in Wistar rats.

Objectives

This study is aimed at investigating the robustness and reproducibility of our previous data using an operant paradigm, which is considered to be a valid and reliable model of human drug consumption, and the ADE, probably the most often used measure of ethanol relapse-drinking behaviour in rats.

Methods

Male Wistar rats with a limited (30-min sessions), intermittent and extended background of ethanol operant self-administration were used. In order to evaluate the efficacy of several DP doses (6.25, 12.5 and 25 mg/kg i.p.) in preventing alcohol relapse, we set up a protocol based on the ADE. In a separate experiment, the effect of DP on spontaneous motor activity of rats was also tested.

Results

A significant ADE was observed in animals treated with saline. DP treatment blocked the increase in ethanol responses following the imposed abstinence period. The higher dose suppressed the ADE and provoked a significant reduction in ethanol consumption with respect to the baseline conditions. Basal motor activity was not altered after DP treatment.

Conclusion

Our positive results with DP, using two different paradigms that evaluate relapse of ethanol drinking, will help to increase the positive predictive value of pre-clinical experiments and offer a solid base to inspire human studies with DP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Alen F, Gomez R, Gonzalez-Cuevas G, Navarro M, Lopez-Moreno JA (2009) Nicotine causes opposite effects on alcohol intake: evidence in an animal experimental model of abstinence and relapse from alcohol. Nicotine Tob Res 11:1304–1311. doi:10.1093/ntr/ntp139

    Article  CAS  PubMed  Google Scholar 

  • Belin-Rauscent A, Fouyssac M, Bonci A, Belin D (2015) How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatr. doi: S0006-3223(15)00047-5

  • Bell RL, Sable HJ, Colombo G, Hyytia P, Rodd ZA, Lumeng L (2012) Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity. Pharmacol Biochem Behav 103:119–155. doi:10.1016/j.pbb.2012.07.007

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Bossert JM, Marchant NJ, Calu DJ, Shaham Y (2013) The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 229:453–476. doi:10.1007/s00213-013-3120-y

    Article  CAS  Google Scholar 

  • Ciccocioppo R (2013) Genetically selected alcohol preferring rats to model human alcoholism. Curr Top Behav Neurosci 13:251–269. doi:10.1007/7854_2012_199

    Article  PubMed  Google Scholar 

  • Correa M, Salamone JD, Segovia KN, Pardo M, Longoni R, Spina L, Peana AT, Vinci S, Acquas E (2012) Piecing together the puzzle of acetaldehyde as a neuroactive agent. Neurosci Biobehav Rev 36:404–430. doi:10.1016/j.neubiorev.2011.07.009

    Article  CAS  PubMed  Google Scholar 

  • Dhaher R, Hauser SR, Getachew B, Bell RL, McBride WJ, McKinzie DL, Rodd ZA (2010) The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats. J Addict Med 4:153–159. doi:10.1097/ADM.0b013e3181bd893f

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Enrico P, Sirca D, Mereu M, Peana AT, Lintas A, Golosio A, Diana M (2009) Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Drug Alcohol Depend 100:265–271. doi:10.1016/j.drugalcdep.2008.10.010

    Article  CAS  PubMed  Google Scholar 

  • Font L, Aragon CM, Miquel M (2006) Voluntary ethanol consumption decreases after the inactivation of central acetaldehyde by d-penicillamine. Behav Brain Res 171:78–86. doi:10.1016/j.bbr.2006.03.020

    Article  CAS  PubMed  Google Scholar 

  • Font L, Miquel M, Aragon CMG (2005) Prevention of ethanol-induced behavioral stimulation by d-penicillamine: a sequestration agent for acetaldehyde. Alcohol Clin Exp Res 29:1156–1164

    Article  CAS  PubMed  Google Scholar 

  • Heyser CJ, Moc K, Koob GF (2003) Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28:1463–1471. doi:10.1038/sj.npp.1300175

    Article  CAS  PubMed  Google Scholar 

  • Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125–133. doi: S0893-133X(97)00130-9

  • Holter SM, Landgraf R, Zieglgansberger W, Spanagel R (1997) Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21:862–868. doi: 00000374-199708000-00014

  • Kera Y, Kiriyama T, Komura S (1985) Conjugation of acetaldehyde with cysteinylglycine, the first metabolite in glutathione breakdown by gamma-glutamyltranspeptidase. Agents Actions 17:48–52

    Article  CAS  PubMed  Google Scholar 

  • Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, Falk DE, Moss H, Huebner R, Noronha A (2012) Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17:513–527. doi:10.1111/j.1369-1600.2012.00454.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lopez-Moreno JA, Gonzalez-Cuevas G, Rodriguez de Fonseca F, Navarro M (2004) Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J Neurosci 24:8245–8252. doi:10.1523/JNEUROSCI.2179-04.2004

    Article  CAS  PubMed  Google Scholar 

  • Marti-Prats L, Sanchez-Catalan MJ, Hipolito L, Orrico A, Zornoza T, Polache A, Granero L (2010) Systemic administration of d-penicillamine prevents the locomotor activation after intra-VTA ethanol administration in rats. Neurosci Lett 483:143–147. doi:10.1016/j.neulet.2010.07.081

    Article  CAS  PubMed  Google Scholar 

  • Melis M, Diana M, Enrico P, Marinelli M, Brodie MS (2009) Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress. Alcohol 43:531–539. doi:10.1016/j.alcohol.2009.05.004

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mobley A, Linder SK, Braeuer R, Ellis LM, Zwelling L (2013) A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic. PLoS One 8:e63221. doi:10.1371/journal.pone.0063221

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Muggironi G, Fois GR, Diana M (2013) Ethanol-derived acetaldehyde: pleasure and pain of alcohol mechanism of action. Front Behav Neurosci 17:87. doi:10.3389/fnbeh.2013.00087

    Google Scholar 

  • Nagasawa HT, Elberling JA, DeMaster EG (1980) Structural requirements for the sequestration of metabolically generated acetaldehyde. J Med Chem 23:140–143

    Article  CAS  PubMed  Google Scholar 

  • Nature Editorial (2013) Reducing our irreproducibility. Nature 496:398

    Article  Google Scholar 

  • Orrico A, Marti-Prats L, Cano-Cebrian MJ, Granero L, Polache A, Zornoza T (2014a) Improved effect of the combination naltrexone/d-penicillamine in the prevention of alcohol relapse-like drinking in rats. J Psychopharmacol 28:76–81. doi:10.1177/0269881113515063

    Article  PubMed  Google Scholar 

  • Orrico A, Marti-Prats L, Cano-Cebrian MJ, Polache A, Zornoza T, Granero L (2014b) Disposition of d-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in rats. Biopharm Drug Dispos 35:284–295. doi:10.1002/bdd.1896

    Article  CAS  PubMed  Google Scholar 

  • Orrico A, Hipolito L, Sanchez-Catalan MJ, Marti-Prats L, Zornoza T, Granero L, Polache A (2013) Efficacy of d-penicillamine, a sequestering acetaldehyde agent, in the prevention of alcohol relapse-like drinking in rats. Psychopharmacology (Berl) 228:563–575. doi:10.1007/s00213-013-3065-1

    Article  CAS  Google Scholar 

  • Peana AT, Muggironi G, Calvisi G, Enrico P, Mereu M, Nieddu M, Boatto G, Diana M (2010) l-Cysteine reduces oral ethanol self-administration and reinstatement of ethanol-drinking behavior in rats. Pharmacol Biochem Behav 94:431–437. doi:10.1016/j.pbb.2009.10.005

    Article  CAS  PubMed  Google Scholar 

  • Peana AT, Enrico P, Assaretti AR, Pulighe E, Muggironi G, Nieddu M, Piga A, Lintas A, Diana M (2008) Key role of ethanol-derived acetaldehyde in the motivational properties induced by intragastric ethanol: a conditioned place preference study in the rat. Alcohol Clin Exp Res 32:249–258. doi:10.1111/j.1530-0277.2007.00574.x

    Article  CAS  PubMed  Google Scholar 

  • Reilly MT, Noronha A, Warren K (2014) Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism. Handb Clin Neurol 125:15–29. doi:10.1016/B978-0-444-62619-6.00002-1

    Article  PubMed  Google Scholar 

  • Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD, McBride WJ (2006) The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav Brain Res 171:207–215. doi: S0166-4328(06)00189-6

  • Rodd ZA, Bell RL, Sable HJ, Murphy JM, McBride WJ (2004) Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav 79:439–450. doi: S0091-3057(04)00275-8.

  • Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 8(12):CD001867. doi: 10.1002/14651858.CD001867.pub2

  • Sanchez-Catalan MJ, Hipolito L, Zornoza T, Polache A, Granero L (2009) Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors. Psychopharmacology (Berl) 204:641–653

    Article  CAS  Google Scholar 

  • Schroeder JP, Overstreet DH, Hodge CW (2005) The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) 179:262–270. doi:10.1007/s00213-005-2175-9

    Article  CAS  Google Scholar 

  • Sirca D, Enrico P, Mereu M, Peana AT, Diana M (2011) l-Cysteine prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Alcohol Clin Exp Res. doi:10.1111/j.1530-0277.2010.01416.x

    PubMed  Google Scholar 

  • Spanagel R, Vengeliene V (2013) New pharmacological treatment strategies for relapse prevention. Curr Top Behav Neurosci 13:583–609. doi:10.1007/7854_2012_205

    Article  CAS  PubMed  Google Scholar 

  • Steckler T (2015) Preclinical data reproducibility for R&D–the challenge for neuroscience. Psychopharmacology (Berl) 232:317–320. doi:10.1007/s00213-014-3836-3

    Article  CAS  Google Scholar 

  • Vengeliene V, Bilbao A, Spanagel R (2014) The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice. Alcohol 48:313–320. doi:10.1016/j.alcohol.2014.03.002

    Article  PubMed  Google Scholar 

  • Walker BM, Koob GF (2008) Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33(3):643–652. doi: 1301438

Download references

Acknowledgments

This research was supported by the European Foundation for Alcohol Research and the Fondo de Investigación Sanitaria (Red de Trastornos Adictivos, FEDER, 12/0028/0015). LM-P is a recipient of an ‘Atracció de Talent’ grant from Universitat de València.

Conflict of interest

All authors report having no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Polache.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martí-Prats, L., Zornoza, T., López-Moreno, J.A. et al. Acetaldehyde sequestration by d-penicillamine prevents ethanol relapse-like drinking in rats: evidence from an operant self-administration paradigm. Psychopharmacology 232, 3597–3606 (2015). https://doi.org/10.1007/s00213-015-4011-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-015-4011-1

Keywords

Navigation